Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05059808
Other study ID # ESA_Survey01
Secondary ID BB 124/21
Status Completed
Phase
First received
Last updated
Start date August 1, 2021
Est. completion date October 30, 2022

Study information

Verified date June 2023
Source University Medicine Greifswald
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this survey is to investigate the current state of sepsis care around Europe. The study is aiming at hospital structure, emergency departments, wards, intensive care units and clinical diagnostic and microbiological service.


Recruitment information / eligibility

Status Completed
Enrollment 1450
Est. completion date October 30, 2022
Est. primary completion date April 30, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Hospitals of all strata Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Belgium Emergency Department Antwerp University Hospital Edegem
Czechia Department of Anesthesiology and Intensive Care Medicine University Hospital of Ostrava Ostrava-Poruba
Denmark Department of Emergency Medicine University of Southern Denmark Odense
Finland Perioperative, Intensive Care and Pain Medicine Helsinki University Hospital Helsinki
France Hopital Raymond Poncare Service de Reanimation Medicale Garches
Germany University Medicine Greifswald Greifswald
Greece 4th Department of Internal Medicine ATTIKON University Hospital Athens
Israel National Institute for Antibiotic Resistance & Infection Control, Ministry of Health Tel Aviv
Italy Ospedale Niguarda Ca' Granda Milano Milan
Moldova, Republic of State University of Medicine and Pharmaceutics "Nicolae Testemitanu" Chi?inau
Netherlands University Medical Center Groningen Groningen
Norway St Olavs hospital Trondheim
Poland Department of Anaesthesiology and Intensive Therapy Wroclaw Medical University Wroclaw
Portugal Universidade do Porto Faculdade de Medicina: Porto Porto
Romania "Prof CC Iliescu" Emergency Institute for Cardiovascular Diseases, Bucharest Bucharest
Russian Federation Vladimir L. Vanevskii Department of Anaesthesiology and Reanimatology, North-Western State Medical University named after Ilya I. Mechnikov St. Petersburg
Spain Corporació Sanitària Parc Taulí · critical care center, sabadell hospital, Corporació Sanitaria Universitaria Parc Tauli Sabadell
Sweden Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University Lund
Turkey Hacettepe University, Department of Internal Medicine Sihhiye, Ankara Ankara
United Kingdom King's College London, Guy's and St Thomas' Foundation Hospital, Department of Critical Care, London London

Sponsors (9)

Lead Sponsor Collaborator
University Medicine Greifswald Becton, Dickinson and Company, European Sepsis Alliance, European Shock Society, European Society for Emergency Medicine (EUSEM) Research Network, European Society of Anaesthesiology and Intensive Care, European Society of Clinical Microbiology and Infectious Diseases, ESGBIES Study Group, European Society of Intensive Care Medicine, Sepsisdialog, Germany

Countries where clinical trial is conducted

Belgium,  Czechia,  Denmark,  Finland,  France,  Germany,  Greece,  Israel,  Italy,  Moldova, Republic of,  Netherlands,  Norway,  Poland,  Portugal,  Romania,  Russian Federation,  Spain,  Sweden,  Turkey,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Questionnaire Structure of sepsis care in Europe 2021
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A